Top 10 Global Insulin Markets Discussed in New Research Report Package Published at MarketPublishers.com
15 May 2012 • by Natalie Aster
LONDON – The worldwide insulin market has been growing at a healthy pace for the last decade, and it is expected to keep it up, at a CAGR of around 20% over the next few years. Among the key factors expected to encourage future growth in the insulin market are acceptance by patients and healthcare professionals, as well as a growing demand for minimally invasive delivery methods. In addition, the introduction of more and more insulin analogs and day-by-day increasing number of diabetic patients will also contribute to the superfluous growth of the insulin market from pole to pole.
New research report package “Insulin - Top 10 Global Markets” developed by Global Research & Data Services offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 10 global markets – the United States, China, Japan, India, Germany, Russia, the United Kingdom, France, Italy and Mexico.
Each analysis covers total market value & volume for insulin, market value & volume for insulin by type (bulk, dosage), product prices. Furthermore, overall country overview, macroeconomic and key doing business indicators in each pertinent country are also provided.
Report Package Details:
Insulin - Top 10 Global Markets
Published: May, 2012
Price: US$ 5.044,00
Report Packages on Top Regional Insulin Markets are Also Available:
- Insulin - Top 5 African Markets
- Insulin - Top 5 American Markets
- Insulin - Top 5 Asian Markets
- Insulin - Top 5 European Markets
More new report packages and separate reports by the publisher can be found at Global Research & Data Services page.